InsidersTradesSigma
Track the 셀트리온제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 셀트리온제약 has recorded 2 reports. Market capitalisation: €1,785.8bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 김주범. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Celltrion Healthcare es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos biosimilares. Cotiza en la Bolsa de Corea, XKRX.